ArticleMolecular cancer therapeutics2023

Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.

Ujjwol Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.